-
Breaking the "zero breakthrough" in domestic syncytial virus prevention, the first approved product is expected to be launched this year during the infection season
Blue Whale Finance Tu Jun Autumn and winter are high incidence seasons for respiratory infectious diseases. In addition to mycoplasma and influenza, respiratory syncytial virus (RSV) is also the most ...